STAT42%
‘Cochlear implant for blindness’ debuts in Europe, could launch in U.S. in 2027 69%
By O. Rose Broderick41%
7/22/2026, 10:00:00 AM
BS Summary: This article contains 15 faulty reasoning types, including Ambiguity (Equivocation), Confirmation Bias, and Burden of Proof, with Appeal to Authority as the most egregious example at 59.3% saturation with 54 hits. Analysis detected 422 faulty-reasoning hits from 91 analyzed words, generating a BS Score of 62.6% and a BS Rank of 69% (6,393 of 20,408 articles). This article is worse (more manipulative) than 68.70% of the article peer group.
Europeans can now receive a device that can partially restore their vision loss.
Americans may not have to wait long to get it, either.
Science Corporation announced Wednesday that European regulators had approved the commercial sale of the startup’s retinal implant that improves eyesight for patients with age-related macular degeneration in their central vision, enough to read books and road signs more clearly.
“We have a cochlear implant for vision now,” said Science founder and CEO Max Hodak.
Speakers
2speakers59%attributed speech37writer words
Voice mapSelect a segment to jump to its words
Selected voice
100%flagged-word coverageScience Corporation
39 attributed words72% of attributed speech100% writer coverage
Attribution is sentence-level. Pattern percentages are calculated only from words assigned to that voice.
Loading…
Loading…
Loading…
Analysis
Hover over highlighted words in the article to view the associated bias or fallacy analysis.